MBCN vs REGN · P/E 14, $273.6M cap vs P/E 14, rev $4.29B
Middlefield Banc (MBCN) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Middlefield Banc (MBCN) is a banks - regional company listed on NASDAQ.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
MBCN does not have a complete income-statement cache yet.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
MBCN currently screens at market cap $273.6M and trailing P/E 14.1. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the MBCN and REGN stock pages for the full models.
Not investment advice.